296 related articles for article (PubMed ID: 33891869)
1. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition.
Stoklund Dittlau K; Krasnow EN; Fumagalli L; Vandoorne T; Baatsen P; Kerstens A; Giacomazzi G; Pavie B; Rossaert E; Beckers J; Sampaolesi M; Van Damme P; Van Den Bosch L
Stem Cell Reports; 2021 Sep; 16(9):2213-2227. PubMed ID: 33891869
[TBL] [Abstract][Full Text] [Related]
2. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
[TBL] [Abstract][Full Text] [Related]
3. Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices.
Stoklund Dittlau K; Krasnow EN; Fumagalli L; Vandoorne T; Baatsen P; Kerstens A; Giacomazzi G; Pavie B; Rossaert E; Beckers J; Sampaolesi M; Van Damme P; Van Den Bosch L
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34570099
[TBL] [Abstract][Full Text] [Related]
4. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms.
Stoklund Dittlau K; Terrie L; Baatsen P; Kerstens A; De Swert L; Janky R; Corthout N; Masrori P; Van Damme P; Hyttel P; Meyer M; Thorrez L; Freude K; Van Den Bosch L
Mol Neurodegener; 2023 Jan; 18(1):5. PubMed ID: 36653804
[TBL] [Abstract][Full Text] [Related]
5. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
[TBL] [Abstract][Full Text] [Related]
6. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of an ALS-associated FUS mutation in
Markert SM; Skoruppa M; Yu B; Mulcahy B; Zhen M; Gao S; Sendtner M; Stigloher C
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33148607
[TBL] [Abstract][Full Text] [Related]
8. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons.
Osaki T; Uzel SGM; Kamm RD
Sci Adv; 2018 Oct; 4(10):eaat5847. PubMed ID: 30324134
[TBL] [Abstract][Full Text] [Related]
9. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
[TBL] [Abstract][Full Text] [Related]
10. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.
Picchiarelli G; Demestre M; Zuko A; Been M; Higelin J; Dieterlé S; Goy MA; Mallik M; Sellier C; Scekic-Zahirovic J; Zhang L; Rosenbohm A; Sijlmans C; Aly A; Mersmann S; Sanjuan-Ruiz I; Hübers A; Messaddeq N; Wagner M; van Bakel N; Boutillier AL; Ludolph A; Lagier-Tourenne C; Boeckers TM; Dupuis L; Storkebaum E
Nat Neurosci; 2019 Nov; 22(11):1793-1805. PubMed ID: 31591561
[TBL] [Abstract][Full Text] [Related]
11. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
[TBL] [Abstract][Full Text] [Related]
12. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
13. HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations.
Fazal R; Boeynaems S; Swijsen A; De Decker M; Fumagalli L; Moisse M; Vanneste J; Guo W; Boon R; Vercruysse T; Eggermont K; Swinnen B; Beckers J; Pakravan D; Vandoorne T; Vanden Berghe P; Verfaillie C; Van Den Bosch L; Van Damme P
EMBO J; 2021 Apr; 40(7):e106177. PubMed ID: 33694180
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor units.
Uzel SG; Platt RJ; Subramanian V; Pearl TM; Rowlands CJ; Chan V; Boyer LA; So PT; Kamm RD
Sci Adv; 2016 Aug; 2(8):e1501429. PubMed ID: 27493991
[TBL] [Abstract][Full Text] [Related]
15. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.
Vandoorne T; Veys K; Guo W; Sicart A; Vints K; Swijsen A; Moisse M; Eelen G; Gounko NV; Fumagalli L; Fazal R; Germeys C; Quaegebeur A; Fendt SM; Carmeliet P; Verfaillie C; Van Damme P; Ghesquière B; De Bock K; Van Den Bosch L
Nat Commun; 2019 Sep; 10(1):4147. PubMed ID: 31515480
[TBL] [Abstract][Full Text] [Related]
16. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
Armstrong GA; Drapeau P
Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
[TBL] [Abstract][Full Text] [Related]
17. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
[TBL] [Abstract][Full Text] [Related]
18. FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration.
Szewczyk B; Günther R; Japtok J; Frech MJ; Naumann M; Lee HO; Hermann A
Cell Rep; 2023 Feb; 42(2):112025. PubMed ID: 36696267
[TBL] [Abstract][Full Text] [Related]
19. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis.
De Santis R; Santini L; Colantoni A; Peruzzi G; de Turris V; Alfano V; Bozzoni I; Rosa A
Stem Cell Reports; 2017 Nov; 9(5):1450-1462. PubMed ID: 28988989
[TBL] [Abstract][Full Text] [Related]
20. Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons.
Shum C; Hedges EC; Allison J; Lee YB; Arias N; Cocks G; Chandran S; Ruepp MD; Shaw CE; Nishimura AL
Stem Cell Reports; 2024 Feb; 19(2):187-195. PubMed ID: 38242131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
